These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1175165)

  • 1. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog.
    Herman EH; Young RS
    Cancer Treat Rep; 1979; 63(11-12):1771-9. PubMed ID: 526912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
    Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Dziegiel P; Jethon Z; Suder E; Sopel M; Rabczyński J; Surowiak P; Zabel M
    Exp Toxicol Pathol; 2002 Feb; 53(6):433-9. PubMed ID: 11926284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.
    Della Torre P; Podestà A; Imondi AR; Moneta D; Sammartini U; Arrigoni C; Terron A; Brughera M
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):355-60. PubMed ID: 11345653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model.
    Kharin S; Krandycheva V; Tsvetkova A; Strelkova M; Shmakov D
    Fundam Clin Pharmacol; 2013 Aug; 27(4):364-72. PubMed ID: 22429163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts.
    Bachmann E; Weber E; Zbinden G
    Agents Actions; 1975 Oct; 5(4):383-93. PubMed ID: 1211314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
    Jensen RA; Acton EM; Peters JH
    Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of amrinone on cardiac toxicity induced by adriamycin in rats.
    Bernardini C; Del Tacca M; Danesi R; Della Torre P
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):243-53. PubMed ID: 3789887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cardiotoxicity of two anthracenediones and doxorubicin in rats.
    Zbinden G; Beilstein AK
    Toxicol Lett; 1982 May; 11(3-4):289-97. PubMed ID: 7101322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.
    Skovsgaard T
    Cancer Chemother Rep; 1975; 59(2 Pt 1):301-8. PubMed ID: 1149008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
    Cini-Neri G; Neri B
    Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat.
    Danesi R; Del Tacca M; Soldani G
    J Pharmacol Methods; 1986 Nov; 16(3):251-9. PubMed ID: 3784571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use].
    Lichinitser MR; Syrkin AB
    Antibiotiki; 1976 Nov; 21(11):1030-2. PubMed ID: 1020931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart.
    Platel D; Bonoron-Adèle S; Robert J
    Pharmacol Toxicol; 2001 May; 88(5):250-4. PubMed ID: 11393585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
    Adamson RH
    Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.